Abstract:Spinal bulbar muscular atrophy (SBMA), the first identified CAG-repeat expansion disorder, is an X-linked neuromuscular disorder involving CAG-repeat-expansion mutations in the androgen receptor (AR) gene. We utilized CRISPR-Cas9 gene editing to engineer novel isogenic human induced pluripotent stem cell (hiPSC) models, consisting of isogenic AR knockout, control and disease lines expressing mutant AR with distinct repeat lengths, as well as control and disease lines expressing FLAG-tagged wild-type and mutant AR, respectively. Adapting a small-molecule cocktail-directed approach, we differentiate the isogenic hiPSC models into motor neuron-like cells with a highly enriched population to uncover cell-type-specific mechanisms underlying SBMA and to distinguish gain- from loss-of-function properties of mutant AR in disease motor neurons. We demonstrate that ligand-free mutant AR causes drastic mitochondrial dysfunction in neurites of differentiated disease motor neurons due to gain-of-function mechanisms and such cytotoxicity can be amplified upon ligand (androgens) treatment. We further show that aberrant interaction between ligand-free, mitochondria-localized mutant AR and F-ATP synthase is associated with compromised mitochondrial respiration and multiple other mitochondrial impairments. These findings counter the established notion that androgens are requisite for mutant AR-induced cytotoxicity in SBMA, reveal a compelling mechanistic link between ligand-free mutant AR, F-ATP synthase and mitochondrial dysfunction, and provide innovative insights into motor neuron-specific therapeutic interventions for SBMA.

Widespread Nuclear and Cytoplasmic Accumulation of Mutant Androgen Receptor in SBMA Patients.

[Transcriptional Regulation and Subcellular Localization of Mutant Androgen Receptor in Spinal and Bulbar Muscular Atrophy].

[In Vitro Aggregation and Cellular Toxicity of Mutant Androgen Receptor Protein in Spinal and Bulbar Muscular Atrophy].

Disease mechanism, biomarker and therapeutics for spinal and bulbar muscular atrophy (SBMA)

Reduced mesencephalic astrocyte-derived neurotrophic factor expression by mutant androgen receptor contributes to neurodegeneration in a model of spinal and bulbar muscular atrophy pathology

Polyglutamine expansion induced dynamic misfolding of Androgen Receptor

Ligand-free Mitochondria-Localized Mutant AR-induced Cytotoxicity in Spinal Bulbar Muscular Atrophy

Dysregulated synaptic gene expression in oligodendrocytes of spinal and bulbar muscular atrophy

Molecular Mechanisms and Therapeutics for SBMA/Kennedy's Disease

Heat Shock Protein 70 Chaperone Overexpression Ameliorates Phenotypes of the Spinal and Bulbar Muscular Atrophy Transgenic Mouse Model by Reducing Nuclear-Localized Mutant Androgen Receptor Protein

Spinal and Bulbar Muscular Atrophy Combined with Hypertrophic Cardiomyopathy and Brugada‐pattern Electrocardiographic Changes: A Case Report

Case report: Klinefelter syndrome may protect against the development of spinal and bulbar muscular atrophy

ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor

One case of spinal bulbar muscular atrophy misdiagnosed as polymyositis: Case report

Sodium Butyrate Ameliorates Phenotypic Expression in a Transgenic Mouse Model of Spinal and Bulbar Muscular Atrophy

Pharmacological Induction of Heat-Shock Proteins Alleviates Polyglutamine-Mediated Motor Neuron Disease.

Differentially disrupted spinal cord and muscle energy metabolism in spinal and bulbar muscular atrophy

Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy

Genotype-phenotype correlation in Chinese patients with spinal and bulbar muscular atrophy.

Antagonistic effect of cyclin-dependent kinases and a calcium-dependent phosphatase on polyglutamine-expanded androgen receptor toxic gain of function

Transgenic Mice with an Expanded Cag Repeat Controlled by the Human Ar Promoter Show Polyglutamine Nuclear Inclusions and Neuronal Dysfunction Without Neuronal Cell Death